New drugs for old habits
Article Abstract:
New treatments for addiction to alcohol andother drugs include Merck Lipha's acamprosate. New treatments may take some time to be accepted, partly because addiction is sometimes seen as a moral rather than a medical issue. Distribution and administration methods of treatments could also be improved. Neurosearch is developing a cocaine treatment that prevents the drug from boosting dopomaine levels. Other research uses the immune system to combat abuse. Drug companies may be reluctant to develop treatments for abuse where users tend to be poor, despite the benefits to the wider economy of such treatments.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Trials and tribulations
Article Abstract:
Clinical trials are the last step of the research and development process of drugs, and the most intensely regulated. Clinical trials occur in three stages, Phase I, Phase II, and Phase III. Contract-Research Organizations (CROs) use massive parallel computing power to help in the research process.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: America's golden opportunity. The perils of privatisation. Straight talk on Social Security
- Abstracts: Ahold acquires once more. The rise and fall of the biotech. Swiss mergers go global
- Abstracts: Bad year for chip makers. Kim quits as head of party
- Abstracts: Battling Bill wins a round. Copyrights and copywrongs. Not off the hook
- Abstracts: Investment pours into British pubs. A private place in retail. Arcadia sells brands